Similarly, despite a role for Th17 effectors in protective immunity27,28, other studies have attributed elevated circulating Th17 numbers29 and higher proportions of CD4+IFNγ+IL17+ T-cells in blood and pleural fluid from low responding subjects with active TB, to poor clinical outcome30. This evidence concerns the gene IL17A and tuberculosis.